Content is not available

Luminex Corporation  

12212 Technology Boulevard
Austin,  TX  78727

United States
http://www.luminexcorp.com
  • Booth: 1838

Profile

Luminex is committed to creating innovative, breakthrough solutions to help our customers improve health and advance science worldwide. We serve the needs of our customers in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, including genomic and proteomic research, personalized medicine, biodefense research and food safety. Our goal is to transform global healthcare and life science research through the development, manufacturing, and marketing of proprietary instruments and assays that deliver cost-effective, rapid results to clinicians and researchers. For further information on Luminex Corporation please visit http://www.luminexcorp.com/.

 Products

  • VERIGENE® Respiratory Pathogens Flex Test
    The VERIGENE® Respiratory Pathogens Flex Test (RP Flex) detects 16 viral and bacterial respiratory targets in a cost-effective manner—one platform, one comprehensive panel, and the flexibility to use and pay for only what you need. For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions....
       

    • The VERIGENE® Respiratory Pathogens Flex Test (RP Flex) is an automated, multiplexed, flexible nucleic acid test for the identification of the viruses and bacteria that most commonly cause respiratory infections. Respiratory testing needs vary by season, geography, and even from patient to patient. With 16 targets, RP Flex addresses the full spectrum of respiratory testing needs in a cost-effective manner—one platform, one comprehensive panel, and the flexibility to use and pay for only what you need. Visit Luminex at booth 1838 to learn more. 

    For In Vitro Diagnostic Use. Products are region specific and may not be approved in some countries/regions.

  • ARIES® C. difficile Assay
    The ARIES® C. difficile Assay is a rapid method for the detection of toxigenic C. difficile from a stool sample, using the sample to answer ARIES® Systems. The assay detects toxins A and B, with built-in controls to ensure accurate results....
         

    • The ARIES® C. difficile Assay is now available to meet your needs. The assay is a rapid method for the detection of toxigenic C. difficile from a stool sample using the sample to answer ARIES® Systems. Assay features include:

    • Ability to detect toxin A and toxin B
    • Built-in controls to ensure accurate results
    • Simplified workflow for minimal hands-on time

    ARIES® Systems are crafted to increase laboratory efficiency, ensure result accuracy, and fit seamlessly into today's lean laboratory. Visit Luminex at booth 1838 to learn more.

 Additional Info

Included in the Export Interest Directory?
No
Business Needs:
Direct Sales
Countries of Interest:
United Kingdom, United States, US Minor Outlying Islands

Categories

Categories
  • Cancer Markers
  • Genetic Testing
  • Genomics
  • Immunoassay Diag/Reagents/Kits
  • Immunoassay Systems
  • Infectious Disease Testing
  • Influenza Testing
  • Molecular Diagnostics (DNA/RNA)
  • Multiplex Testing
  • Pharmacogenomics
  • Rapid Tests
  • STD Testing
  • Viral Testing
    • Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Appointment Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined